The data on menarche is conflicting, however, as a case-control study found an increased risk of anti-citrullinated protein antibody (ACPA)-positive RA with menarche at ≥15 vs. ≤ 12 years (44). The gene discussed is PRTN3; the disease is rheumatoid arthritis.